- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4107
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Bioteque Corporation · Healthcare · Medical Instruments & Supplies
Latest close
114.0 TWD
-2.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 37.5% of its 52-week range. The latest completed week returned -2.1%, after a 2.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
39
out of 100
Latest Close
114.0 TWD
14 Aug 2026
1W Return
-2.1%
latest completed week
4W Return
2.1%
short-term follow-through
12W Return
2.6%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 44.46% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.1%
Latest completed week; four-week move 2.1%.
Indicator stack
20/86
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.46%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 37.5% of its 52-week range. The latest completed week returned -2.1%, after a 2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.1% over four weeks, 2.6% over 12 weeks, and 3.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.83Latest activity-pressure read.
Pressure change266.4%Four-week change in activity pressure.
Leadership-29.21Latest relative-leadership reading.
RS change-1.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.5%Distance below the 52-week high.
13-week volatility1.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher12 of 2612 weeks finished lower.
Best week+4.3%Week of 10 Apr.
Worst week-2.4%Week of 17 Apr.
Latest week-2.1%Week of 14 Aug.
Shape of recent returns
Strong gains1
Modest gains11
Flat weeks2
Modest losses12
Sharp losses0
Recent vol1.5%13-week weekly-return volatility.
Base vol1.8%52-week weekly-return volatility.
Up/down split25/25Count of positive and negative weeks in the 52-week window.
Average skew1.6% / -1.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank34 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Medical Instruments & Supplies
4-week rank11 / 23
Group average2.2%
Trend breadth26.1%
Trend26.1%active weekly trend signals
MD56.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.24; No reversal markers Next-Week ExpectancyNegative 44.46%Next-week expectancy is negative with a 44.46% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 114.0 TWD | -2.1% | 113.0 TWD | 110.1 TWD | 0.83 | -29.21 | 228.4K | Off |
| 7 Aug 2026 | 116.5 TWD | 2.6% | 113.1 TWD | 110.0 TWD | 0.54 | -25.92 | 232.0K | Off |
| 31 Jul 2026 | 113.5 TWD | 0.4% | 113.1 TWD | 109.9 TWD | 0.20 | -26.72 | 474.9K | Off |
| 24 Jul 2026 | 113.0 TWD | 1.3% | 113.2 TWD | 109.8 TWD | -0.13 | -28.67 | 206.0K | Off |
| 17 Jul 2026 | 111.6 TWD | 0.0% | 113.2 TWD | 109.7 TWD | -0.50 | -28.72 | 407.9K | Off |
| 10 Jul 2026 | 111.6 TWD | 0.4% | 113.3 TWD | 109.6 TWD | -0.65 | -33.66 | 313.1K | Off |
| 3 Jul 2026 | 111.1 TWD | 1.3% | 113.6 TWD | 109.5 TWD | -0.77 | -36.72 | 448.0K | Off |
| 26 Jun 2026 | 109.7 TWD | -0.4% | 113.9 TWD | 109.4 TWD | -0.97 | -35.26 | 354.7K | Off |
| 19 Jun 2026 | 110.2 TWD | -2.1% | 114.2 TWD | 109.3 TWD | -0.98 | -38.38 | 294.5K | Off |
| 12 Jun 2026 | 112.6 TWD | 1.3% | 114.5 TWD | 109.2 TWD | -0.89 | -34.56 | 317.2K | Off |
| 5 Jun 2026 | 111.1 TWD | 1.7% | 114.8 TWD | 109.1 TWD | -0.80 | -37.46 | 542.3K | Off |
| 29 May 2026 | 109.2 TWD | -1.7% | 115.0 TWD | 109.0 TWD | -0.78 | -38.88 | 846.4K | Off |
| 22 May 2026 | 111.1 TWD | -1.7% | 115.2 TWD | 108.9 TWD | -0.88 | -35.05 | 687.2K | Off |
| 15 May 2026 | 113.0 TWD | 1.3% | 115.5 TWD | 108.8 TWD | -0.98 | -32.98 | 596.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.